Brigette Roberts

Brigette Roberts

Director/Miembro de la Junta en QUINCE THERAPEUTICS, INC. .

Fortuna: - $ al 31/05/2026

Finance
Health Technology
Consumer Services

Perfil

Brigette Michelle Roberts is the founder of YYC Capital Management LLC, founded in 2009.
Dr. Roberts is currently Chief Executive Officer & Director at OrphAI Therapeutics, Inc. since 2021.
Dr. Roberts is also Director & Chief Corporate Affairs Officer at Quince Therapeutics, Inc. starting in 2026.
Former positions include Director at Ligand Pharmaceuticals, Inc. from 2005 to 2007, Principal at Third Point Management Co. LLC from 2005 to 2008, Associate at Thomas Weisel Partners LLC from 2001 to 2002, Principal at Nomura Securities International, Inc. in 2012, and Principal at Sturzas Institutional Research, Inc. in 2003.
Education includes an undergraduate degree from Harvard University in 1995 and a doctorate from New York University in 1999.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/05/2026 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Brigette Roberts

EmpresasCargoInicio
QUINCE THERAPEUTICS, INC. Director/Miembro de la Junta 18/05/2026
Director Ejecutivo -

Antiguos cargos conocidos de Brigette Roberts.

EmpresasCargoFin
Corporate Officer/Principal 01/12/2012
Fundador 01/01/2012
Gestor de Cartera-Acciones -
LIGAND PHARMACEUTICALS INCORPORATED Director/Miembro de la Junta 01/03/2007
Corporate Officer/Principal 01/01/2003
Ver el detalle de la experiencia de Brigette Roberts.

Formación de Brigette Roberts.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

98

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Finance

Consumer Services

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Brigette Roberts